There are still some unsolved questions, for example, the concentration of irisin in pathophysiological conditions that are highly controversial; some studies suggest that the irisin level rises in patients with obesity or cancer, but why does irisin not play a role in burning and “ERK-ing” the fat as well as inhibiting the development of cancer? Here, FNDC5 is linked to Obesity.